Clinical trial
Randomized Controlled Trial of Magnesium Sulfate Versus Placebo on the Prevention of Atrial Fibrillation Post Cardiac Surgery.
NCT05669417 is registered in ClinicalTrials.gov with HagaZiekenhuis as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Controlled Trial of Magnesium Sulfate Versus Placebo on the Prevention of Atrial Fibrillation Post Cardiac Surgery.
- Lead sponsor
- HagaZiekenhuis
- Phase
- Phase 2/3
- Overall status
- Terminated
- Start date
- August 1, 2022
- Completion date
- August 6, 2023
- Enrollment
- 265 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
atrial fibrillation new onset